Britain will host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported, citing people involved in the project.

GlaxoSmithKline opened a new $13 million research hub in London focused on artificial intelligence.

U.S.-based Merck is moving ahead with the company’s $1.3 billion research center in London.

Greater Than One announced the opening of a new office in London, known as GTO Global, to bolster the company’s partnerships with marketers in the region.